Does catheter-based renal denervation reduce blood pressure and maintain safety in patients with resistant hypertension?
Catheter-based renal denervation provides safe and sustained reductions in blood pressure over 9 years in patients with resistant hypertension.
RDN results in a significant and robust reduction in both office and ambulatory systolic and diastolic BP at ≈9-year FU after catheter-based RDN on less medication and without evidence of adverse consequences on renal function.
Sesa‐Ashton et al. (Fri,) studied this question.